| Denumire comercială | DCI | Forma farmaceutică | Cod ATC | Cod CIM | Firma / țara deținătoare APP |  |
 |
 |
 |
 |
|
|---|---|---|---|---|---|---|---|---|---|---|---|
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129007 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129008 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 100 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63129009 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125001 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125002 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125003 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125004 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125005 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125006 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125007 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125008 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 12 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63125009 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126001 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126002 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126003 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126004 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126005 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126006 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126007 | LAVIPHARM S.A. - GRECIA | ||||||
| FENTANYL LAVIPHARM 25 micrograme/h | FENTANYLUM | PLASTURE TRANSDERMIC | N02AB03 | W63126008 | LAVIPHARM S.A. - GRECIA |
ANMDMR - Nomenclatorul medicamentelor pentru uz uman